speb/financial-data huggingface dataset:
MEDANTA.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -1302780000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -852200000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -1028670000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Common Stock: 537380000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 537380000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 39615700000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 39615700000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 240210000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Common Stock Payments: -98240000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 8163700000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 8163700000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 9968010000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2465290000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Current Assets: 16749200000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 16749200000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 330300000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 330300000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Current Debt: 299590000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 299590000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 629890000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 629890000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 6271310000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 6271310000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 1585570000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 1585570000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Depreciation: 2225400000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 2225400000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 2225400000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 665180000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 2225400000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 665180000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 269136449.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 5.35
MEDANTA.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 5564600000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1439880000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — EBIT: 7941310000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — EBIT: 2139870000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — EBITDA: 10166710000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — EBITDA: 2805050000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — End Cash Position: 1273330000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 2718530000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -2641960000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -790000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 6579680000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1869280000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 162030000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 162030000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 39109190000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 39109190000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Gross Profit: 34134650000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 9125180000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Interest Expense: 791140000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 267080000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 791140000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 267080000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -724080000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 775640000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Inventory: 789830000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 789830000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 45926450000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 45926450000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -10891110000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 1142380000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1142380000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 240210000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 3686640000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 5259410000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 5259410000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 6011160000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 6011160000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 11270570000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 11270570000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 3686640000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -121150000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 1139210000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 1139210000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 227050000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 227050000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Minority Interests: 23920000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 23150000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 141970000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Net Debt: 5037420000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 5037420000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 25570000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Net Income: 5564600000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Net Income: 1439880000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 5564600000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1439880000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 5540680000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1416530000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 5564600000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1439880000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 5564600000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1439880000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 7150170000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 5540680000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1416530000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -1403970000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Net Interest Income: -791140000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -267080000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -1889350000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 3565490000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 3565490000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -791140000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -267080000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Net PPE: 39109190000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 39109190000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -8373430000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 39453670000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 39453670000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 156460000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 156460000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 10176920000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 2805050000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Normalized Income: 5572511747.94
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 1439880000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 7143910000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Operating Income: 6965580000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Operating Income: 1772450000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Operating Revenue: 44102660000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 11590470000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 268698932.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 268698932.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 223650000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 223650000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 299870000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 299870000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 39078320000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 39078320000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 162030000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 162030000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -695650000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1176000000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1176000000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 522810000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 522810000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 985940000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 367420000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 7402910000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1971300000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Other Properties: 30945490000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 30945490000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 10350540000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 10350540000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Other Special Charges: 170060000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Payables: 2423700000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Payables: 2423700000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Pretax Income: 7150170000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 1872790000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -5230000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -1403970000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -1889350000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -8381900000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 9968010000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2465290000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 2225400000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 665180000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -121150000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: -98240000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: -159850000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 8470000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 6579680000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1869280000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Share Issued: 268698932.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 268698932.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Special Income Charges: -10210000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 382980000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 39615700000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 39615700000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 39453670000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 39453670000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -2298252.06
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Tax Provision: 1609490000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 456260000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.23
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
MEDANTA.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -1194190000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Total Assets: 59050040000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 59050040000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 45626860000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 45626860000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Total Debt: 11900460000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 11900460000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 39842750000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 39842750000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Total Expenses: 37137080000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 9818020000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 19207290000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 19207290000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 42300840000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 42300840000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 12935980000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 12935980000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -10210000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
MEDANTA.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -10210000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Working Capital: 10477890000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 10477890000.00
MEDCL.PA income_statement (annual, 2022-03-31) — +Operating Expense: 27906000.00
MEDCL.PA income_statement (annual, 2022-03-31) — +Total Revenue: 4090000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Accounts Payable: 2982000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Accounts Receivable: 799000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -3838000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 6913000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 131000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Basic Average Shares: 24865403.00
MEDCL.PA income_statement (annual, 2022-03-31) — Basic EPS: -1.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Beginning Cash Position: 47095000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 2697000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Capital Expenditure: -1974000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 3478000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Capital Stock: 251000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 24617000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 26585000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Cash Equivalents: 5000000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Cash Financial: 19617000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Change In Inventory: 0.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: -1005000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Change In Payable: 26000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Change In Receivables: -1388000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Change In Working Capital: -2367000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Changes In Cash: -22478000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Common Stock: 251000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Common Stock Equity: -13371000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Common Stock Issuance: 48000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Common Stock Payments: -192000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Construction In Progress: 128000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Cost Of Revenue: 0.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Current Assets: 34074000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 581000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Current Debt: 27765000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 28346000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Current Deferred Assets: 1135000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Current Liabilities: 38241000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Current Provisions: 102000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Deferred Tax: 0.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Depreciation: 1516000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 1516000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 306000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Depreciation Income Statement: 306000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Diluted Average Shares: 24865403.00
MEDCL.PA income_statement (annual, 2022-03-31) — Diluted EPS: -1.00
MEDCL.PA income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: -24806000.00
MEDCL.PA income_statement (annual, 2022-03-31) — EBIT: -22962000.00
MEDCL.PA income_statement (annual, 2022-03-31) — EBITDA: -21446000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — End Cash Position: 24617000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Financing Cash Flow: -800000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Free Cash Flow: -23336000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -3000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 1666000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 799000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Gross PPE: 10868000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Gross Profit: 4090000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Held To Maturity Securities: 94000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Interest Expense: 1844000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 1844000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Interest Income: 0.00
MEDCL.PA income_statement (annual, 2022-03-31) — Interest Income Non Operating: 0.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Interest Paid Cff: -1126000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Interest Received Cfi: 95000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Inventory: 0.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Invested Capital: 30643000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Investing Cash Flow: -316000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 225000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 48000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Issuance Of Debt: 3308000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 2897000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Long Term Debt: 16249000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 19146000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 3308000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -2307000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 13000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Long Term Provisions: 20000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1172000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Minority Interest: 0.00
MEDCL.PA income_statement (annual, 2022-03-31) — Minority Interests: 0.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: -144000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Net Debt: 19397000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Net Income: -24806000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Net Income Common Stockholders: -24806000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Net Income Continuous Operations: -24806000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: -24806000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: -24806000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: -24806000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: -24806000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Net Intangibles Purchase And Sale: -351000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Net Interest Income: -1847000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 1547000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 1001000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 1001000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -1847000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Net PPE: 7030000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -1607000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Net Tangible Assets: -15037000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Non Current Deferred Assets: 41000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 0.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 0.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 265000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 94000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Normalized EBITDA: -21426000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Normalized Income: -24786000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Operating Cash Flow: -21362000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Operating Income: -23816000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Operating Revenue: 4090000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 25108498.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Other Current Assets: 22000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 107000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Other Equity Interest: 1000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 1666000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Other Non Cash Items: 1818000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 1000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 2000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Other Operating Expenses: 2079000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Other Properties: 6871000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Other Receivables: 20000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 1968000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Other Special Charges: 2000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Payables: 3116000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1283000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Prepaid Assets: 50000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Pretax Income: -24806000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Properties: 0.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: 86000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Purchase Of Intangibles: -351000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Purchase Of PPE: -1623000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 0.00
MEDCL.PA income_statement (annual, 2022-03-31) — Reconciled Depreciation: 1516000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Rent And Landing Fees: 604000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 604000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Repayment Of Debt: -2307000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -192000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Research And Development: 23607000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Restricted Cash: 592000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Retained Earnings: -24806000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Sale Of PPE: 16000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 732000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Selling General And Administration: 732000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Share Issued: 25148703.00
MEDCL.PA income_statement (annual, 2022-03-31) — Special Income Charges: -2000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Stock Based Compensation: 2394000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Stockholders Equity: -13371000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Tangible Book Value: -15037000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
MEDCL.PA income_statement (annual, 2022-03-31) — Tax Provision: 0.00
MEDCL.PA income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Taxes Receivable: 4871000.00
MEDCL.PA cash_flow (annual, 2022-03-31) — Taxes Refund Paid: 0.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Total Assets: 44303000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Total Capitalization: 2878000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Total Debt: 47492000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: -13371000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Total Expenses: 27906000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 57674000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 10229000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 19433000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Total Operating Income As Reported: -23812000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Total Other Finance Cost: 3000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Total Tax Payable: 134000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Total Unusual Items: -20000.00
MEDCL.PA income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -20000.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Treasury Shares Number: 40205.00
MEDCL.PA balance_sheet (annual, 2022-03-31) — Working Capital: -4167000.00
MEDCL.PA income_statement (annual, 2023-03-31) — +Operating Expense: 33989000.00
MEDCL.PA income_statement (annual, 2023-03-31) — +Total Revenue: 9944000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Accounts Payable: 4177000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Accounts Receivable: 2093000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -4632000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 7416000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 439000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Basic Average Shares: 25188499.00
MEDCL.PA income_statement (annual, 2023-03-31) — Basic EPS: -1.27
MEDCL.PA cash_flow (annual, 2023-03-31) — Beginning Cash Position: 24617000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 2394000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Capital Expenditure: -1027000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 3187000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Capital Stock: 253000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 6467000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 6470000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Cash Equivalents: 0.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Cash Financial: 6467000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Change In Inventory: 0.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 1559000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Change In Payable: 1196000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Change In Receivables: -5791000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Change In Working Capital: -3036000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Changes In Cash: -18151000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Common Stock: 253000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Common Stock Equity: -42294000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Common Stock Issuance: 810000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Construction In Progress: 259000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Cost Of Revenue: 0.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Current Assets: 19568000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 643000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Current Debt: 39758000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 40401000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Current Deferred Assets: 744000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Current Liabilities: 57025000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Current Provisions: 1006000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Deferred Tax: 0.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Depreciation: 1665000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 1665000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 384000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Depreciation Income Statement: 384000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 0.00
MEDCL.PA income_statement (annual, 2023-03-31) — Diluted Average Shares: 25188499.00
MEDCL.PA income_statement (annual, 2023-03-31) — Diluted EPS: -1.27
MEDCL.PA income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -32010000.00
MEDCL.PA income_statement (annual, 2023-03-31) — EBIT: -28078000.00
MEDCL.PA income_statement (annual, 2023-03-31) — EBITDA: -26413000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — End Cash Position: 6467000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Financing Cash Flow: 1556000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Free Cash Flow: -22032000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 33000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 1926000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 2093000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Gross PPE: 11005000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Gross Profit: 9944000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Held To Maturity Securities: 112000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Interest Expense: 3932000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 3932000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Interest Income: 1000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Interest Income Non Operating: 1000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Interest Paid Cff: -4460000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Interest Received Cfi: 44000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Inventory: 0.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Invested Capital: 9172000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Investing Cash Flow: 1298000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 551000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 810000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Issuance Of Debt: 29976000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 2544000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Long Term Debt: 11708000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 14252000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 29976000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -24148000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 15000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 3910000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Minority Interest: 0.00
MEDCL.PA income_statement (annual, 2023-03-31) — Minority Interests: 0.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 810000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Net Debt: 44999000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Net Income: -32010000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -32010000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -32010000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -32010000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -32010000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -32010000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -32010000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -451000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Net Interest Income: -9174000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 2233000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 5828000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 5828000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -9174000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Net PPE: 6373000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -528000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Net Tangible Assets: -44220000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Non Current Deferred Assets: 28000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 354000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 112000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Normalized EBITDA: -26413000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Normalized Income: -32010000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Operating Cash Flow: -21005000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Operating Income: -24045000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Operating Revenue: 9944000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 25280495.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Other Current Assets: 55000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 126000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Other Equity Interest: -1000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 1926000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Other Non Cash Items: 9097000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -2000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 2000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Other Operating Expenses: 2737000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Other Properties: 4442000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Other Receivables: 10000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 3000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Payables: 4763000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1898000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Prepaid Assets: 26000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Pretax Income: -32010000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Properties: 0.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 967000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -451000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Purchase Of PPE: -576000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 0.00
MEDCL.PA income_statement (annual, 2023-03-31) — Reconciled Depreciation: 1665000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Rent And Landing Fees: 853000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 853000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Repayment Of Debt: -24148000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Research And Development: 27925000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Restricted Cash: 0.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Retained Earnings: -32010000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Sale Of PPE: 48000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 629000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Selling General And Administration: 629000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Share Issued: 25288045.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Stock Based Compensation: 2279000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Stockholders Equity: -42294000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Tangible Book Value: -44220000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
MEDCL.PA income_statement (annual, 2023-03-31) — Tax Provision: 0.00
MEDCL.PA income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Taxes Receivable: 10170000.00
MEDCL.PA cash_flow (annual, 2023-03-31) — Taxes Refund Paid: 0.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Total Assets: 29339000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Total Capitalization: -30586000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Total Debt: 54653000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: -42294000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Total Expenses: 33989000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 71633000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 9772000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 14608000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Total Operating Income As Reported: -24046000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Total Other Finance Cost: 5243000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Total Tax Payable: 586000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Total Unusual Items: -37000.00
MEDCL.PA income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -37000.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 7550.00
MEDCL.PA balance_sheet (annual, 2023-03-31) — Working Capital: -37457000.00
MEDCL.PA income_statement (annual, 2024-03-31) — +Operating Expense: 30135000.00
MEDCL.PA income_statement (annual, 2024-03-31) — +Total Revenue: 9160000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Accounts Payable: 1849000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1474000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -5397000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 31014000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 422000.00
MEDCL.PA income_statement (annual, 2024-03-31) — Basic Average Shares: 29071067.00
MEDCL.PA income_statement (annual, 2024-03-31) — Basic EPS: -0.86
MEDCL.PA cash_flow (annual, 2024-03-31) — Beginning Cash Position: 6467000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 2215000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Capital Expenditure: -1191000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 2902000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Capital Stock: 291000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 19460000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 19460000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Cash Equivalents: 5159000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Cash Financial: 19460000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 562000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Change In Payable: -2328000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Change In Receivables: 4944000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Change In Working Capital: 3178000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Changes In Cash: 12993000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Common Stock: 291000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Common Stock Equity: -40824000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Common Stock Issuance: 23321000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Common Stock Payments: -25000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Construction In Progress: 37000.00
MEDCL.PA income_statement (annual, 2024-03-31) — Cost Of Revenue: 0.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Current Assets: 27258000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 643000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Current Debt: 5518000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 6161000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Current Deferred Assets: 966000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Current Liabilities: 16466000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Deferred Tax: 88000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Depreciation: 1719000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 1719000.00
MEDCL.PA income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 411000.00
MEDCL.PA income_statement (annual, 2024-03-31) — Depreciation Income Statement: 411000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 5745000.00
MEDCL.PA income_statement (annual, 2024-03-31) — Diluted Average Shares: 29071067.00
MEDCL.PA income_statement (annual, 2024-03-31) — Diluted EPS: -0.86
MEDCL.PA income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -25038000.00
MEDCL.PA income_statement (annual, 2024-03-31) — EBIT: -20333000.00
MEDCL.PA income_statement (annual, 2024-03-31) — EBITDA: -18614000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 0.00
MEDCL.PA cash_flow (annual, 2024-03-31) — End Cash Position: 19460000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Financing Cash Flow: 25528000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Free Cash Flow: -13113000.00
MEDCL.PA cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: 296000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 2451000.00
MEDCL.PA balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 2254000.00